GALNT9 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
RP11-527L4.2 | Uncharacterized protein | | | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TAL2 | T-cell acute lymphocytic leukemia 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
TMEM72 | Transmembrane protein 72 | Predicted membrane proteins
| | | | | Tissue enriched |
AC008948.1 | | Predicted membrane proteins
| | | | | Tissue enriched |
C10orf67 | Chromosome 10 open reading frame 67 | | | | | | Group enriched |
CHST13 | Carbohydrate (chondroitin 4) sulfotransferase 13 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CTSV | Cathepsin V | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CYP27B1 | Cytochrome P450, family 27, subfamily B, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
EMX1 | Empty spiracles homeobox 1 | Transcription factors
| | | | | Tissue enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GGACT | Gamma-glutamylamine cyclotransferase | Enzymes
| | | | | Tissue enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
KCNJ16 | Potassium inwardly-rectifying channel, subfamily J, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LYG1 | Lysozyme G-like 1 | Predicted secreted proteins
| | | | | Group enriched |
MNS1 | Meiosis-specific nuclear structural 1 | | | | | | Group enriched |
MYLK4 | Myosin light chain kinase family, member 4 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PKHD1 | Polycystic kidney and hepatic disease 1 (autosomal recessive) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
PVALB | Parvalbumin | | | | | | Group enriched |
RAB11FIP3 | RAB11 family interacting protein 3 (class II) | Cancer-related genes
| | | | | Tissue enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
RP11-536G4.1 | Uncharacterized protein | | | | | | Tissue enriched |
SIM1 | Single-minded family bHLH transcription factor 1 | Plasma proteins Transcription factors
| | | | | Tissue enriched |
SLC16A12 | Solute carrier family 16, member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC23A3 | Solute carrier family 23, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SLC27A2 | Solute carrier family 27 (fatty acid transporter), member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
TMEM132E | Transmembrane protein 132E | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TNFRSF11B | Tumor necrosis factor receptor superfamily, member 11b | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TRPV5 | Transient receptor potential cation channel, subfamily V, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
C10orf126 | Chromosome 10 open reading frame 126 | | | | | | Tissue enriched |
CLCN5 | Chloride channel, voltage-sensitive 5 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |